RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA Houston, TX and St. Louis, MO, March 11, 2020 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced the U.S. Food and Drug Administration (FDA) has granted copper Cu 64...

Pancreatic Endocrine Tumor Pipeline Review: Demand for Novel Therapies Rises on Account of Low Survival Rate Associated with the Disease, says Fortune Business Insights Pune, June 19, 2019 (GLOBE NEWSWIRE) --  The global Pancreatic Endocrine Tumor Market will witness growth in the coming years due to recent advancements made in surgical procedures for removal of...